Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | E-602 |
Trade Name | |
Synonyms | E602|E 602 |
Drug Descriptions |
E-602 is a sialidase Fc fusion that removes terminal sialic acid residues from tumor cell surface sialoglycans, potentially leading to restoration of immune function, dendritic cell priming and activation of T-lymphocytes (Cancer Res 2022;82(12_Suppl):Abstract nr LB203). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187111 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
E-602 | E-602 | 0 | 1 |
E-602 + Pembrolizumab | E-602 Pembrolizumab | 0 | 1 |